Walter Z, Szostek M, Mensah P, Lorenz F, Weglarska D, Skotnicki A B
Kliniki Hematologii Collegium Medicum, Uniwersytetu Jagielońskiego w Krakowie.
Przegl Lek. 1999;56 Suppl 1:22-7.
Autological transplantation of bone marrow as well as hematopoietic and precursor cells obtained from peripheral blood with the use of cell apheresis is a therapy applied in the treatment of hematological diseases and solid tumours. The mobilization of hematopoietic cells is performed by applying cytostatic drugs and/or recombinant growth factors (G-CSF, GM-CSF). The collection of CD 34+ cells is performed by using cell separators. An important role in the transplantation procedure is played by purging techniques of transplantation material from residual neoplastic cells (negative selection) or isolation of hematopoietic cells (positive selection). The considerable progress in this field is connected with the implementation of Immunoadsorbtive or magnetic methods as well as those of molecular biology. The improvement of the procedure of hematopoietic cells transplantation and its efficacy is caused by the stimulation of the hematopoiesis by using the combination of cytokines (G-CSF, GM-CSF, IL-3, SCF) and purging of the hematopoietic cells obtained from the cellular apheresis.
自体骨髓移植以及使用细胞单采术从外周血获取的造血细胞和祖细胞移植是一种用于治疗血液系统疾病和实体瘤的疗法。造血细胞的动员通过应用细胞毒性药物和/或重组生长因子(粒细胞集落刺激因子、粒细胞-巨噬细胞集落刺激因子)来进行。CD 34+细胞的采集通过使用细胞分离器来完成。清除移植材料中残留肿瘤细胞的技术(阴性选择)或造血细胞的分离(阳性选择)在移植过程中发挥着重要作用。该领域的显著进展与免疫吸附或磁性方法以及分子生物学方法的应用有关。造血细胞移植程序及其疗效的改善是通过使用细胞因子组合(粒细胞集落刺激因子、粒细胞-巨噬细胞集落刺激因子、白细胞介素-3、干细胞因子)刺激造血以及清除从细胞单采术中获得的造血细胞来实现的。